Cardinal Health, Inc.
Location
Ohio
Founded
1979-02-28
Website
Risk Signals
3281 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Medical, Dental, and Hospital Equipment and Supplies, Drugs, Drug Proprietaries, and Druggists' Sundries, Management Services), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about Cardinal Health, Inc.
Live alerts from global media, monitored by Business Radar
2025-04-23 (beckersasc.com)
Inside the standout physician group deals of 2024 -
Although physician medical group transaction volume declined by approximately 20% in 2024 compared to 2023, according to VMG Health, several high-profile acquisitions still took place. In its 2025 Healthcare M&A Report, released on April 22, VMG highlighted eight of the most significant physician group deals of the year. 1. In January 2024, private equity firm […]
Read more
2025-03-20 (beckersasc.com)
Who's snapping up physicians? 20 deals to know -
Here are 20 deals in the last two years to know involving physician practice and group acquisitions: Private equity-backed groups Amazon Optum CVS Other acquisitions to note:
Read more
2024-10-26 (virginiabusiness.com)
Reston cybersecurity firm names CFO -
Listen to this article Reston-based LookingGlass Cyber Solutions Inc. announced last week it has hired Dana Mariano as its chief financial officer. With more than 20 years of cybersecurity experience, Mariano has overseen acquisitions of three early-stage tech companies to public entities, including Invincea to Sophos; NetWitness to RSA Security; and CareFusion to CardinalHealth. "As […]
Read more
(fiercepharma.com)
Cardinal Health unloads China business to Shanghai Pharma for $557M
China’s government-owned Shanghai Pharma is shelling out more than $550 million to buy the China operations of U.S.-based Cardinal Health, a move that will make Shanghai the largest forei | China’s government-owned Shanghai Pharma is shelling out more than $550 million to buy the China operations of U.S.-based Cardinal Health, a move that will make Shanghai the largest drug distributor in the country.
Read more